Sector: MedicalCYTORI THERAPEUTICS (NASDAQ: CYTX)
Headlines
- Cytori Therapeutics to Webcast Third Quarter Financial Results on November 9, 2009
Nov 02, 2009 07:00 AM | CYTX
- CORRECTING and REPLACING Cytori to Webcast Presentation at the 2009 BIOCOM Investor Conference on October 27
Oct 27, 2009 11:44 AM | CYTX
- BioMed News Bytes: Cytori (NASDAQ: CYTX), Questcor (NASDAQ: QCOR)
Oct 16, 2009 01:41 AM | CYTX
- Adipose-Derived Stem and Regenerative Cells Show Potential in First-in-Man Treatment of Stress Urinary Incontinence
Oct 15, 2009 09:59 PM | CYTX
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- The Next Big Thing In Health Care: How To Profit From Immunotherapy & Regenerative Medicine
Oct 07, 2009 03:27 PM | BBI, BMRN, BMY, CVM, CYTX, DNA
- BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte
Sep 24, 2009 07:06 PM | CAM, CEPH, CHTP, CYTX, DNA, DNDN
- StockPreacher.com Issues Cautious Trading Outlook for Osiris Therapeutics Inc.
Sep 24, 2009 06:52 AM | BIIB, CYTX, GENZ, OSIR
- Cytori Reports Preclinical Results that Suggest Adipose-Derived Regenerative Cells may Reverse Periodontal Disease
Sep 14, 2009 07:00 AM | CYTX
- Cytori Therapeutics Announces Fall U.S. Medical Conference Presentation Schedule; Interim RESTORE-2 Results to be Reported in December
Sep 09, 2009 07:00 AM | CYTX
- StockPreacher.com Issues Trading Outlook for Advanced Cell Technology Inc.
Aug 24, 2009 06:51 AM | CYTX, GERN
- Cytori Reports 2nd Quarter 2009 Financial Results
Aug 10, 2009 07:51 AM | CYTX
- Cytori Therapeutics 2nd Quarter Financial Results Conference Call & Shareholder Letter
Aug 07, 2009 04:45 PM | CYTX
- Cytori Therapeutics to Webcast Second Quarter Financial Results on August 10, 2009
Jul 27, 2009 07:05 AM | CYTX
- Cytori Comments on Patent Appeal
Jul 24, 2009 09:54 AM | CYTX
- Cytori’s Celution® 700 System to be Regulated as a Medical Device by U.S. FDA
Jul 17, 2009 07:04 AM | CYTX
- Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Jul 13, 2009 08:31 AM | ACCP, CYTX, ECTE, JLI, NABI
- Cytori Expands Patent Protection for the Celution® System and Uses for Adipose Derived Stem and Regenerative Cells
Jul 13, 2009 07:52 AM | CYTX
- Cytori Expands Patent Protection for the Celution® System and Uses for Adipose Derived Stem and Regenerative Cells
Jul 13, 2009 07:06 AM | CYTX
- InvestorSoup.com Researches: Oracle, Comcast, Cytori, Wal-Mart, Abbot and GT Solar
Jul 01, 2009 08:20 AM | ABT, CMCSA, CYTX, ORCL, WMT
- Form 4 CYTORI THERAPEUTICS, For: May 20 Filed by: CALHOUN CHRISTOPHER J (10K)
May 20, 2009 08:59 PM
- Form 4 CYTORI THERAPEUTICS, For: May 15 Filed by: CALHOUN CHRISTOPHER J (10K)
May 18, 2009 09:09 PM
- Form 4 RICKEY DAVID For: May 07 (10K)
May 11, 2009 09:31 PM
- Form 4 HENRIKSEN RONALD D For: May 07 (10K)
May 11, 2009 09:30 PM
- Form 4 HEDRICK MARC H For: May 07 (10K)
May 11, 2009 09:28 PM
- Form 4 Arm Douglas M For: Apr 30 (10K)
May 04, 2009 10:00 PM
- Form 4 RICKEY DAVID For: Apr 30 (10K)
May 04, 2009 09:49 PM
- Form 4 HOLMES E CARMACK For: Apr 30 (10K)
May 04, 2009 09:47 PM
- Form 4 CYTORI THERAPEUTICS, For: Apr 30 Filed by: HAWRAN PAUL W (10K)
May 04, 2009 09:44 PM
- Form 4 Hawkins Richard J For: Apr 30 (10K)
May 04, 2009 09:44 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CYTX
|
Compare to S&P
|
| YTD |
-8.86 %
|
-20.56 %
|
| 4 Weeks |
-10.11 %
|
-11.06 %
|
| 12 Weeks |
2.49 %
|
-0.05 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 90.00 %
|
|
EPS Growth in Last Year: 93.94 %
|
|
Sales Growth in Last Quarter: -33.21 %
|
|
Sales Growth in Last Quarter: -9.05 %
|
|
